Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $77 | $153 | $154 | $506 |
| - Cash | $808 | $995 | $959 | $1,508 |
| + Debt | $1,329 | $1,387 | $1,702 | $1,347 |
| Enterprise Value | $598 | $545 | $896 | $345 |
| Revenue | $1,333 | $2,498 | $4,216 | $6,169 |
| % Growth | -46.6% | -40.8% | -31.7% | – |
| Gross Profit | $513 | $654 | $817 | $1,289 |
| % Margin | 38.5% | 26.2% | 19.4% | 20.9% |
| EBITDA | -$346 | -$143 | -$261 | $201 |
| % Margin | -25.9% | -5.7% | -6.2% | 3.3% |
| Net Income | -$554 | -$220 | -$293 | $136 |
| % Margin | -41.6% | -8.8% | -7% | 2.2% |
| EPS Diluted | -136.64 | -7.84 | -10.84 | 5.24 |
| % Growth | -1,642.9% | 27.7% | -306.9% | – |
| Operating Cash Flow | -$24 | $43 | -$117 | -$332 |
| Capital Expenditures | -$1 | -$2 | -$1 | -$45 |
| Free Cash Flow | -$26 | $41 | -$119 | -$377 |